Literature DB >> 11925103

Normal breast epithelial cells induce apoptosis of breast cancer cells via Fas signaling.

Robert-Alain Toillon1, Simon Descamps, Eric Adriaenssens, Jean-Marc Ricort, David Bernard, Bénoni Boilly, Xuefen Le Bourhis.   

Abstract

Fas/Fas ligand (Fas L) death pathway is an important mediator of apoptosis. Deregulation of Fas pathway is reported to be involved in the immune escape of breast cancer and the resistance to anti-cancer drugs. In this study, we demonstrated that conditioned medium by normal breast epithelial cells (NBEC-CM) induced apoptosis of MCF-7 and T-47D Fas-sensitive cells but had no effect on MDA-MB-231 Fas-resistant cells. Inhibition of PI3 kinase or NF-kappaB by specific inhibitors or transient transfections restored the sensitivity of MDA-MB-231 cells to NBEC-induced apoptosis. Moreover, the constitutive activation of NF-kappaB was controlled by PI3 kinase because inhibition of PI3 kinase reduced NF-kappaB activity. Inducible activation of NF-kappaB rendered MCF-7 cells resistant to NBEC-CM- and Fas agonist antibody-triggered apoptosis. Therefore, constitutive or inducible activation of PI3 kinase and/or NF-kappaB in breast cancer cells rendered them resistant to NBEC-triggered apoptosis. In addition, Fas neutralizing antibody and dominant negative Fas abolished NBEC-triggered apoptosis. Western blot and confocal microscopy analysis showed an increase of membrane Fas/Fas L when cells were induced into apoptotis by NBEC-CM. Taken together, these data show that NBEC induced apoptosis in breast cancer cells via Fas signaling. Copyright 2002 Elsevier Science (USA).

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11925103     DOI: 10.1006/excr.2002.5490

Source DB:  PubMed          Journal:  Exp Cell Res        ISSN: 0014-4827            Impact factor:   3.905


  14 in total

1.  FAS Death Receptor: A Breast Cancer Subtype-Specific Radiation Response Biomarker and Potential Therapeutic Target.

Authors:  Janet K Horton; Sharareh Siamakpour-Reihani; Chen-Ting Lee; Ying Zhou; Wei Chen; Joseph Geradts; Diane R Fels; Peter Hoang; Kathleen A Ashcraft; Jeff Groth; Hsiu-Ni Kung; Mark W Dewhirst; Jen-Tsan A Chi
Journal:  Radiat Res       Date:  2015-10-21       Impact factor: 2.841

2.  Oleandrin-mediated expression of Fas potentiates apoptosis in tumor cells.

Authors:  Yashin Sreenivasan; Pongali B Raghavendra; Sunil K Manna
Journal:  J Clin Immunol       Date:  2006-06-16       Impact factor: 8.317

3.  Anti-gastric cancer active immunity induced by FasL/B7-1 gene-modified tumor cells.

Authors:  Shi-Ying Zheng; De-Chun Li; Zhi-De Zhang; Jun Zhao; Jin-Feng Ge
Journal:  World J Gastroenterol       Date:  2005-06-07       Impact factor: 5.742

4.  Norsolorinic acid from Aspergillus nidulans inhibits the proliferation of human breast adenocarcinoma MCF-7 cells via Fas-mediated pathway.

Authors:  Clay C C Wang; Yi-Ming Chiang; Po-Lin Kuo; Jiunn-Kae Chang; Ya-Ling Hsu
Journal:  Basic Clin Pharmacol Toxicol       Date:  2008-03-16       Impact factor: 4.080

Review 5.  Proteomics in studies of signal transduction in epithelial cells.

Authors:  Serhiy Souchelnytskyi
Journal:  J Mammary Gland Biol Neoplasia       Date:  2002-10       Impact factor: 2.673

6.  CD4+T cells in CIKs (CD4+ CIKs) reversed resistance to fas-mediated apoptosis through CD40/CD40L ligation rather than IFN-gamma stimulation.

Authors:  Jinpu Yu; Weihong Zhang; Huawei Jiang; Hui Li; Shui Cao; Xinbao Ren
Journal:  Cancer Biother Radiopharm       Date:  2008-06       Impact factor: 3.099

7.  Estradiol-induced regression in T47D:A18/PKCalpha tumors requires the estrogen receptor and interaction with the extracellular matrix.

Authors:  Yiyun Zhang; Huiping Zhao; Szilard Asztalos; Michael Chisamore; Yasmin Sitabkhan; Debra A Tonetti
Journal:  Mol Cancer Res       Date:  2009-04       Impact factor: 5.852

8.  Stat3-siRNA induces Fas-mediated apoptosis in vitro and in vivo in breast cancer.

Authors:  Sateesh Kunigal; Sajani S Lakka; Prasanna Kumar Sodadasu; Norman Estes; Jasti S Rao
Journal:  Int J Oncol       Date:  2009-05       Impact factor: 5.650

9.  Evaluation of in vitro anti-proliferative and immunomodulatory activities of compounds isolated from Curcuma longa.

Authors:  Grace G L Yue; Ben C L Chan; Po-Ming Hon; Mavis Y H Lee; Kwok-Pui Fung; Ping-Chung Leung; Clara B S Lau
Journal:  Food Chem Toxicol       Date:  2010-05-09       Impact factor: 6.023

10.  Inhibitory effect of HGF on invasiveness of aggressive MDA-MB231 breast carcinoma cells, and role of HDACs.

Authors:  E Ridolfi; E Matteucci; P Maroni; M A Desiderio
Journal:  Br J Cancer       Date:  2008-10-21       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.